Joshua Alinger  alingerj@wustl.edu

Researcher, Rheumatology
Rheumatology

phone: (314) 454-6124

Recent Publications view all (5)


Publication Co-Authors

  1. Glycolytic requirement for NK cell cytotoxicity and cytomegalovirus control. JCI Insight. 2017;2(23). PMCID:PMC5752285  PMID:29212951 
  2. VP24-Karyopherin Alpha Binding Affinities Differ between Ebolavirus Species, Influencing Interferon Inhibition and VP24 Stability. J Virol. 2017;91(4). PMCID:PMC5286879  PMID:27974555 
  3. Ebola virus VP24 targets a unique NLS binding site on karyopherin alpha 5 to selectively compete with nuclear import of phosphorylated STAT1. Cell Host Microbe. 2014;16(2):187-200. PMCID:PMC4188415  PMID:25121748 
  4. Lipids derived from virulent Francisella tularensis broadly inhibit pulmonary inflammation via toll-like receptor 2 and peroxisome proliferator-activated receptor α. Clin Vaccine Immunol. 2013;20(10):1531-40. PMCID:PMC3807199  PMID:23925884 
  5. Francisella tularensis SchuS4 and SchuS4 lipids inhibit IL-12p40 in primary human dendritic cells by inhibition of IRF1 and IRF8. J Immunol. 2013;191(3):1276-86. PMCID:PMC3729262  PMID:23817430 
Last updated: 04/04/2018
© 2018 by Washington University in St. Louis
One Brookings Drive, St. Louis, MO 63130